West Nile Virus Surveillance in Europe – Monthly Report
West Nile Virus in 2025: A Comprehensive Guide to Understanding the Current Outbreak and Protecting Yourself
Table of Contents
As of August 13, 2025, europe is experiencing a concerning rise in West Nile Virus (WNV) cases, with six countries reporting 202 locally acquired infections. While current numbers are slightly above the decade average, understanding the virus, its transmission, symptoms, and preventative measures is crucial for public health and individual wellbeing. This article provides a definitive guide to West Nile Virus, covering the current situation, long-term risks, and how to protect yourself and your family.
What is West Nile Virus?
West Nile Virus is a mosquito-borne zoonotic virus - meaning it can be transmitted from animals to humans. It belongs to the Flaviviridae family, wich also includes viruses like Zika, dengue, and yellow fever. Originally discovered in the West Nile district of Uganda in 1937, WNV has spread globally, with significant outbreaks occurring in North America, Europe, Africa, asia, and Australia.
The virus circulates primarily in a bird-mosquito-bird cycle. mosquitoes become infected when thay feed on infected birds. Humans and other mammals (like horses) can then become infected when bitten by these infected mosquitoes. Humans are considered “dead-end hosts” because the virus doesn’t typically reach high enough concentrations in our blood to infect other mosquitoes, thus preventing further spread from person to person.
The 2025 European Outbreak: A Current Snapshot
As of August 6,2025,the European Center for Disease Prevention and Control (ECDC) reports locally acquired human cases of WNV in Italy,Greece,France,Romania,Bulgaria,and Hungary. Specifically:
Italy: Is currently experiencing the most significant outbreak, with 168 confirmed human infections and 10 fatalities. Cases have been reported in previously unaffected provinces of Latina and Frosinone.
Greece: 26 cases have been reported.
France: 3 cases, including one with an unknown place of infection.
Romania: Has reported its first cases in Sălaj County.
Bulgaria & Hungary: Each report 1 case.
A total of 40 regions across these six countries are affected, compared to 108 regions across 11 countries during the same period in 2024 and 68 regions in seven countries in 2018. While the 2025 case numbers are slightly above the average for the past decade, they remain lower than the intense circulation seen in 2024 and 2018.
This year’s outbreak is notable for a high hospitalization rate (100% of cases), likely due to surveillance focusing on severe cases. The case fatality rate currently stands at 7%, comparable to the 11% observed in the previous decade. Neurological manifestations are present in 56% of cases,slightly lower than the 66% seen previously,but still a significant concern.
You can find the full automated report from the ECDC here.
Symptoms of West Nile Virus
Approximately 80% of people infected with West Nile Virus experience no symptoms. For those who do, symptoms typically appear between 2 and 14 days after a mosquito bite. The severity of symptoms varies widely:
West Nile Fever (Mild Cases): The most common presentation, accounting for around 20% of infections. Symptoms include:
Fever
headache
body aches
Skin rash
fatigue
Swollen lymph nodes
Severe Cases (Neurological involvement): Less than 1% of infected individuals develop severe neurological illness. This can manifest as:
West nile meningitis: Inflammation of the membranes surrounding the brain and spinal cord. Symptoms include headache, stiff neck, nausea, vomiting, and sensitivity to light.
West Nile Encephalitis: Inflammation of the brain itself. Symptoms include headache, high fever, disorientation, seizures, coma, and paralysis.
Acute Flaccid Paralysis: A polio-like syndrome causing weakness or paralysis in limbs.
Diagnosis and treatment
Diagnosing West Nile Virus involves a combination of clinical evaluation and laboratory testing. Tests include:
* Blood Tests: To detect antibodies against the virus (IgM and IgG